{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-028154","form_type":"8-K","ticker":"IONS","cik":"0000874015","company_name":"IONIS PHARMACEUTICALS INC","filed_at":"2026-07-10T01:03:42+00:00","discovered_at":"2026-07-10T10:05:00.271139+00:00","generated_at":"2026-07-10T10:05:26.667247+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ionis reaffirms FY 2026 financial guidance unchanged from April 29 release","bullets":["Reaffirmed FY 2026 financial guidance on July 9, 2026.","Guidance unchanged from that provided on April 29, 2026 in Q1 earnings release.","No specific financial figures disclosed in this filing; refer to prior release."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-028154","json":"https://secwatch.observer/filing/0001140361-26-028154.json","markdown":"https://secwatch.observer/filing/0001140361-26-028154.md","text":"https://secwatch.observer/filing/0001140361-26-028154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874015/000114036126028154/0001140361-26-028154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874015/000114036126028154/ef20077783_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T10:05:26.667247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}